JPT is an ISO 9001 certified provider of innovative peptide products and services and a partner for research projects focusing on applications in Immunology, Immunotherapy & Vaccine Development, Proteomics & Enzyme Profiling. JPT contributes to the effort to combat cancer and infectious diseases with state of the art peptide tools for research, monitoring of clinical trials, and vaccine development. Our Bestsellers are Custom Peptides We are the experts in producing even complex custom designed peptides and conjugated peptides for many applications PepStar Custom designed peptide microarrays for incubation with a variety of biological samples (e.g. patient sera, antibodies, enzymes and others) during seromarker screening, enzyme profiling or immune monitoring. We also offer peptide microarray incubation and analyses services. PepTrack Flexible peptide library assembly tailored for each application PepMix Peptide pools for antigen specific T-cell stimulation during T-cell assays (e.g. for immune monitoring during disease or after vaccination) SpikeTides Proteotypic light or heavily labeled peptides for protein biomarker quantification Please visit our webpage for further information! JPT Peptide Technologies GmbH Represented by the Management Board: Dr. Holger Wenschuh, Sean Marett, Dr. Sierk Poetting Volmerstr. 5 D- 12489 Berlin Telephone: +49 30 6392 5500 Fax: +49 30 6392 5501 Email: info@jpt.com Registration Court: Berlin / Amtsgericht Charlottenburg, HRB 92692 VAT identification number: DE 814044483 Imprint: https://www.jpt.com/support-contact/corporate/imprint/ Privacy Policy: https://www.jpt.com/support-contact/corporate/privacy-policy/
